Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China · Delayed Price · Currency is CNY

7.11

+0.01 (0.14%)

Feb 27, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Respiratory System Drugs	988.92M	-	-	-	-
Digestive System Drugs	146.06M	-	-	-	-
Systemic Anti-Infectives Drugs	128.84M	-	-	-	-
Other Medicines	97.62M	-	-	-	-
Active Pharmaceutical Ingredient (api)	52.10M	-	-	-	-
Total	1.41B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.41B	1.80B	1.52B	1.35B	1.16B
China Growth	-21.26%	18.49%	11.91%	16.53%	-11.04%
Total	1.41B	1.80B	1.52B	1.35B	1.16B
Total Growth	-21.26%	18.49%	11.91%	16.53%	-11.04%

Source: S&P Global Market Intelligence.